HCA Healthcare, Inc. revenue by year
Over the 10 fiscal years shown, revenue went from $41.49B (year ended Dec 31, 2016) to $75.60B (year ended Dec 31, 2025), a compound annual growth rate of 6.9%. The fastest growth was +14.0% in the year ended Dec 31, 2021; the weakest year was +0.4% (year ended Dec 31, 2020).
Annual revenue
| Fiscal year ended | Revenue (USD) | Change | XBRL concept | Reported in |
|---|---|---|---|---|
| Dec 31, 2025 | $75.60B | +7.1% | Revenues | 10-K filed Feb 10, 2026 |
| Dec 31, 2024 | $70.60B | +8.7% | Revenues | 10-K filed Feb 10, 2026 |
| Dec 31, 2023 | $64.97B | +7.9% | Revenues | 10-K filed Feb 10, 2026 |
| Dec 31, 2022 | $60.23B | +2.5% | Revenues | 10-K filed Feb 14, 2025 |
| Dec 31, 2021 | $58.75B | +14.0% | Revenues | 10-K filed Feb 16, 2024 |
| Dec 31, 2020 | $51.53B | +0.4% | Revenues | 10-K filed Feb 17, 2023 |
| Dec 31, 2019 | $51.34B | +10.0% | Revenues | 10-K filed Feb 18, 2022 |
| Dec 31, 2018 | $46.68B | +7.0% | RevenueFromContractWithCustomerIncludingAssessedTax | 10-K filed Feb 19, 2021 |
| Dec 31, 2017 | $43.61B | +5.1% | RevenueFromContractWithCustomerIncludingAssessedTax | 10-K filed Feb 20, 2020 |
| Dec 31, 2016 | $41.49B | — | RevenueFromContractWithCustomerIncludingAssessedTax | 10-K filed Feb 21, 2019 |
HCA Healthcare, Inc. reported revenue under 2 different XBRL concepts across these years (often after the 2018 change in revenue-recognition rules, ASC 606). Each row shows the concept used, so you can judge comparability.
Quarterly revenue
Quarters reported in 10-Q filings. Fourth quarters are usually reported only inside the annual 10-K, so they are not listed separately here; we do not estimate them.
| Quarter | Revenue (USD) | vs same quarter a year earlier | Source |
|---|---|---|---|
| 3 months ended Sep 30, 2026 | $19.85B | +3.6% | 10-Q filed Oct 29, 2026 |
| 3 months ended Jun 30, 2026 | $20.23B | +8.7% | 10-Q filed Jul 28, 2026 |
| 3 months ended Mar 31, 2026 | $19.11B | +4.3% | 10-Q filed Apr 29, 2026 |
| 3 months ended Sep 30, 2025 | $19.16B | +9.6% | 10-Q filed Oct 29, 2026 |
| 3 months ended Jun 30, 2025 | $18.61B | +6.4% | 10-Q filed Jul 28, 2026 |
| 3 months ended Mar 31, 2025 | $18.32B | +5.7% | 10-Q filed Apr 29, 2026 |
| 3 months ended Sep 30, 2024 | $17.49B | +7.9% | 10-Q filed Oct 30, 2025 |
| 3 months ended Jun 30, 2024 | $17.49B | +10.3% | 10-Q filed Aug 4, 2025 |
Source: SEC EDGAR XBRL company facts for CIK 860730 (raw data). Most recent filing in this dataset: 10-Q filed Oct 29, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.